Study blood clots and heart disease in adults with Von Willebrand
Part of Blood & lymphatic, Genetic & congenital, Heart & circulation clinical trials.
This study looks at cardiovascular problems and blood-clot events (like deep vein clots or pulmonary embolism) in adults with Von Willebrand disease in western France. It may help doctors better understand who is at risk and how to manage these complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Von Willebrand disease
- You are an adult
- You receive care/follow-up at a reference center in western France (Caen, Brest, Nantes, Rennes, Le Mans, or Angers)
- You agree to be included in the BERHLINGO database
- You have had a blood clot or embolism, or a heart/artery condition such as deep vein thrombosis, pulmonary embolism, stroke/TIA, acute coronary syndrome, atrial fibrillation, or related leg artery problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects information about people with bleeding disorders like hemophilia A or B and von Willebrand disease. The goal is to better understand these conditions and improve care across participating treatment centers.
This trial tests a new lab device that measures how well your body forms primary blood clots while blood is kept in flowing conditions. It may help doctors better assess bleeding or clotting tendencies and guide future care.
This Phase 1/2 study tests VGA039 in healthy adults and people with von Willebrand disease (VWD). The goal is to see if the drug is safe and how it affects bleeding-related factors, especially in people who have symptoms.
This study uses special video imaging to try to predict when bleeding may happen in certain inherited bleeding disorders. It may help doctors better anticipate bleeding and guide safer care.
This study looks at how well a Von Willebrand disease treatment plan works during pregnancy, and whether some patients need extra “adjusting” of medicine. It may help prevent bleeding problems by matching treatment to each person’s lab results later in pregnancy.
This study is testing a new treatment for people with certain types of Von Willebrand disease (Type 1 or 2A) who have frequent bleeding problems. It aims to see if the treatment can help reduce these bleeding episodes.
Hear when a new Von Willebrand Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.